Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related ...

Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing ...

Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related cancers, especially colorectal cancer, according to data released on Thursday ...

New research has found that GLP-1 drugs can substantially reduce the risk of obesity-related cancers — and they’re more ...

Ozempic and Rybelsus have been approved ... “They also improve insulin sensitivity, which can lower the risk of insulin-resistant conditions linked to cancer.” Obesity is a chronic health ...

The data showed patients who took GLP-1 drugs had a much lower risk of developing cancer than those who took DDP-4s.

A former head of the US Food and Drug Administration cut his body fat in half using GLP-1 drugs. In his book, he compares the ...

“More serious but less common risks include pancreatitis, acute kidney injury, retinopathy and thyroid cancer,” says Amidor. Below, Dr. Gould and Amidor offer their tips for safe use of Ozempi ...

Ozempic use can potentially cause issues including thyroid cancer, pancreatitis ... "It was just a waste of money and time." Given the risk of side effects, Emini-Sadiku said Ozempic was "by ...